Gemini Therapeutics (GMTX) Stock Chart & Stock Price History $69.28 +1.50 (+2.21%) As of 10/6/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrendsBuy This Stock Gemini Therapeutics Stock Price Performance The Gemini Therapeutics (GMTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 38.75%, with a year-to-date return of 12.47%. In the past month, the stock has increased 15.10%, reflecting recent market activity. As of the latest close, Gemini Therapeutics traded at $67.78 with a market cap of $2.94 billion and volume of 272,220 shares. Receive GMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+3.34%1 Month Performance+15.10%3 Month Performance+26.54%Year-To-Date Performance+12.47%1 Year Performance+38.75% GMTX Stock Chart for Tuesday, October, 7, 2025 GMTX Chart by TradingView Gemini Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/06/2025$67.78$67.78$67.92$65.43272,220 shs$2.94 billion10/03/2025$67.04$65.86-1.76%$67.28$65.26367,291 shs$2.85 billion10/02/2025$66.08$67.04+1.45%$68.79$65.88475,637 shs$2.90 billion10/01/2025$65.06$66.08+1.57%$66.58$64.89375,991 shs$2.86 billion09/30/2025$65.55$65.06-0.75%$68.43$64.40398,594 shs$2.82 billion09/29/2025$65.55$65.55$65.94$61.97352,247 shs$2.84 billion09/26/2025$62.39$62.50+0.18%$62.88$60.49227,824 shs$2.71 billion09/25/2025$62.16$62.39+0.37%$63.53$61.04172,194 shs$2.70 billion09/24/2025$61.50$62.16+1.08%$63.29$61.24327,715 shs$2.69 billion09/23/2025$60.79$61.50+1.16%$62.51$59.74235,643 shs$2.66 billion Get the Latest News and Ratings for GMTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/22/2025$60.79$60.79$62.98$60.25878,158 shs$2.63 billion09/19/2025$61.04$62.63+2.61%$62.64$60.58516,904 shs$2.71 billion09/18/2025$60.34$61.04+1.15%$63.54$59.65418,250 shs$2.64 billion09/17/2025$59.90$60.34+0.73%$61.51$59.66294,953 shs$2.61 billion09/16/2025$59.82$59.90+0.13%$60.12$58.36318,640 shs$2.60 billion09/15/2025$59.82$59.82$61.04$59.37178,558 shs$2.59 billion09/12/2025$59.94$60.29+0.58%$61.27$59.94150,749 shs$2.61 billion09/11/2025$60.34$59.94-0.66%$61.00$58.59318,138 shs$2.60 billion09/10/2025$61.91$60.34-2.54%$65.25$60.09571,992 shs$2.61 billion09/09/2025$60.76$61.91+1.89%$63.20$60.23767,019 shs$2.68 billion09/08/2025$60.76$60.76$61.93$60.09196,285 shs$2.63 billion Related Companies Roivant Sciences Stock Price Chart Moderna Stock Price Chart Elanco Animal Health Stock Price Chart Qiagen Stock Price Chart BridgeBio Pharma Stock Price Chart Verona Pharma PLC American Depositary Share Stock Price Chart Revolution Medicines Stock Price Chart Merus Stock Price Chart Grifols Stock Price Chart Rhythm Pharmaceuticals Stock Price Chart Receive GMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GMTX) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gemini Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gemini Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
